RollingStone Co., Ltd. (KOSDAQ:214610)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Biochemical Diagnosis Division	2.92B	3.22B	2.07B	3.06B	4.95B
Biochemical Diagnosis Division Growth	-9.54%	56.05%	-32.47%	-38.24%	71.85%
Molecular Diagnosis Division	1.01B	1.69B	6.02B	24.79B	38.93B
Molecular Diagnosis Division Growth	-40.61%	-71.88%	-75.70%	-36.33%	3401.45%
Immuno Diagnostic Division	462.86M	413.86M	8.02B	2.46B	1.79B
Immuno Diagnostic Division Growth	11.84%	-94.84%	226.76%	37.47%	1619.07%
Other	255.45M	36.64M	-	-	-
Other Growth	597.20%	-	-	-	-
Total	4.64B	5.37B	16.11B	30.30B	45.67B
Total Growth	-13.55%	-66.69%	-46.83%	-33.65%	1014.47%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Republic of Korea	2.10B	2.29B	7.31B	3.90B	1.71B
Republic of Korea Growth	-8.40%	-68.66%	87.69%	127.73%	-2.17%
Americas	4.94B	120.80M	159.17M	123.40M	71.80M
Americas Growth	3986.09%	-24.11%	28.99%	71.87%	-89.18%
Europe	939.57M	771.02M	1.99B	1.62B	6.64B
Europe Growth	21.86%	-61.18%	22.43%	-75.55%	765.33%
Other	1.69B	2.18B	6.65B	24.66B	37.25B
Other Growth	-22.54%	-67.17%	-73.01%	-33.80%	3952.42%
Total	9.67B	5.37B	16.11B	30.30B	45.67B
Total Growth	80.09%	-66.69%	-46.83%	-33.65%	1014.47%

Source: S&P Global Market Intelligence.